Cardiac Failure Flashcards

1
Q
A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Explain how the RAAS system usually works [+]

A

Angiotensinogen is converted to angiotensin I under the action of renin

Angiotensin I is then converted to angiotensin II under the act of angiotensin converting enzyme (ACE)

Angiotensin II then:

i) proximal tubule: Increases Na+ reabsorbtion, which increases blood flow, which increases BP
ii) adrenal cortex: increases aldosterone, which causes increase Na+ & H20 reabsorbtion in distal tubule, increase bloodflow and BP
iii) systemic arterioles: binds to GPCR = artriolar vasoconstriction = increases BP
iv) brain: stimules release of ADH = increase Na reabsorbtion

This results in the increased volume of the blood which in turn increases blood pressure and thus venous pressure which in turn increases pre-load thereby increasing the stretching of the heart and thus force of contraction and thus stroke volume and thus cardiac output

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Describe what is meant by the term acute heart failure [1]

What is the general aetiological cause of HF? [1]

A

Acute heart failure (AHF) is life-threatening emergency. AHF is a term used to describe the sudden onset or worsening of the symptoms of heart failure.

AHF is usually caused by a reduced cardiac output that results from a functional or structural abnormality.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Describe the pathophysiology of acute onset HF [2]

A

AHF involves the acute failure of the heart to pump blood to meet the body’s demand.

As a result, two courses of pathology develop:

Congestion in the pulmonary or systemic circulation.
* Pulmonary oedema develops when the left ventricle is unable to empty, which increases the hydrostatic pressure in pulmonary vasculature leading to pulmonary oedema and hypoxia.
These patients are ‘WET’.

Hypoperfusion
* of vital organs as the cardiac output is reduced.
* These patients are ‘COLD’.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is de-novo acute heart failure caused by? [4]

Describe pathophysiology of de-novo acute heart failure [3]

A

De-novo acute HF: caused by and increased cardiac filling pressures and myocardial dysfunction usually as a result of ischaemia.

This causes reduced cardiac output & therefore hypoperfusion.

This, in turn can cause pulmonary oedema.

Caused by:
* Ischaemia
* Viral myopathy
* Toxins
* Valve dysfunction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Decompensated heart failure accounts for most cases of AHF.

What are the most common precipitating causes of acute AHF? [4]

A
  • Acute coronary syndrome
  • Hypertensive crisis: e.g. bilateral renal artery stenosis
  • Acute arrhythmia
  • Valvular disease

There is generally a history of pre-existing cardiomyopathy. It usually presents with signs of fluid congestion, weight gain, orthopnoea and breathlessness.

CHAMP

Acute coronary syndrome (ACS)
Hypertensive crisis
Arrhythmias, e.g. atrial fibrillation, ventricular tachycardia, bradyarrhythmia
Mechanical problems, e.g. myocardial rupture as a complication of ACS, valve dysfunction
Pulmonary embolism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q
A

50% of patients will show signs of congestion without signs of hypoperfusion (WET-WARM).
45% of patients will show signs of congestion with signs of hypoperfusion (WET-COLD).
5% of patients will show no signs of congestion (DRY-WARM or DRY-COLD).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Describe how you manage an acute heart failure patient [+]

A

Oxygen
- Patients often require 15L/minute with a reservoir mask.
- reassess and down-titrate oxygen to avoid hyper-oxygenation which is associated with worsening myocardial ischaemia and other pathology.

Loop diuretics:
- All ‘WET’ patients will require diuretics as the cornerstone of their management.
- 40 milligrams furosemide intravenously initially to improve symptoms of congestion fluid overload.

Nitrates:
- sublingual glyceryl trinitrate or intravenous nitrates
- Do not use nitrates in those with SBP < 90mmHg or aortic stenosis, who rely on sufficient preload to overcome their pressure gradient.

NIV:
- for those with cardiogenic pulmonary oedema or dyspnoea
- improves ventilation to reduce respiratory distress and drives fluid out of alveoli

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are the signs [6] and symptoms [4] of AHF?

How does blood pressure present with regards to AHF? [1]

A

Symptoms:
* Breathlessness
* Reduced exercise tolerance
* Oedema
* Fatigue

Signs
* Cyanosis
* Tachycardia
* Elevated jugular venous pressure
* Displaced apex beat
* Chest signs: classically bibasal crackles but may also cause a wheeze
* S3-heart sound

Over 90% of patients with AHF have a normal or increased blood pressure (mmHg).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the difference between Low and High Output Failure?

A

low output failure:
- Traditional concept of heart failure where the heart cannot maintain an adequate cardiac output to meet the demands of the body.
- results in increased systemic vascular resistance in an attempt to maintain mean arterial pressure

High output failure:
- high cardiac output (i.e. > 8L/min)
- heart is unable to meet the increased demand for perfusion despite normal cardiac function.
- The problem is with reduced systemic vascular resistance, often due to diffuse arteriole vasodilatation or shunting
- It is generally due to states of increased metabolic demand (e.g. hyperthyroidism), reduced vascular resistance (e.g. thiamine deficiency, sepsis) or significant shunting (e.g. large arteriovenosu fistula).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Describe what is meant by the Frank-Starling principle [1]

A

Essentially stretching of cardiac muscle (within physiological limits) will increase the force of contraction.

Increased venous pressures lead to increased venous return and raised end diastolic volume (EDV)

This increased EDV means an increase in the preload as there is increased stretch on the cardiomyocytes

This increased stretching - an increase in the length of the sarcomere - leads to a more forceful contraction. In turn, this increase in contractility leads to an increase in the stroke volume.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Describe the pathophsiology of chronic heart failure [+]

A

Chronic heart failure refers to the clinical features of impaired heart function, specifically the function of the left ventricle to pump blood out of the heart and around the body - i.e. the ejection fraction decreases

This increased end-systolic volume (ESV) means the myocardium experiences greater stretch.

In a normal heart, this would lead to an increase in myocardial contractility by the Frank-Starling principle. However, in a failing heart, this causes a reduction in stroke volume (and thus cardiac output). This is because the relationship between cardiomyocyte stretch and contractility cannot continue unfettered.

Impaired left ventricular function results in a chronic backlog of blood waiting to flow into and through the left side of the heart

The left atrium, pulmonary veins and lungs experience an increased volume and pressure of blood.

They start to leak fluid and cannot reabsorb excess fluid from the surrounding tissues, resulting in pulmonary oedema.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Explain how the heart tries to compensate for a failing heart [4]

A

Increasing preload (increasing venous pressures):
* Increases end-diastolic volume (EDV) compensating for the reduced ejection fraction, thus maintaining cardiac output.
* In severe disease, large increases result in pulmonary oedema, ascites and peripheral oedema.

Increasing heart rate (a sinus tachycardia)

Activation of the renin-angiotensin-aldosterone system (RAAS)
* due to renal hypoperfusion from the reduced cardiac output.
* contributes to increased venous pressures through vasoconstriction and there is retention of water and sodium that contributes to oedema.

Sympathetic nervous system activation
* via baroreceptors; increasing myocardial contractility and heart rate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

How do you calculate cardiac output? [1]

A

cardiac output = stroke volume x heart rate

  • Heart rate: number of times the heart beats each minute
  • Stroke volume: the amount of blood pumped by the left ventricle with each contraction
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

How do you work out MAP? [1]

A

MAP = diastolic blood pressure + 1/3rd of the pulse pressure

MAP is dependent on the cardiac output and systemic vascular resistance
* Cardiac output: the amount of blood pumped out the heart each minute. Measured in litres per minute (L/min).
* Systemic vascular resistance: resistance to blood flow offered by all of the systemic vasculatures, excluding the pulmonary vasculature.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Describe why right sided heart failure may occur [4]

A

Right-sided heart failure commonly occurs as a result of advanced left-sided failure.

Primary right-sided heart failure is uncommon and broadly related to three categories:
* Pulmonary hypertension
* Pulmonary/Tricuspid valve disease
* Pericardial disease

Also:
* Pneumonia
* Pulmonary embolism (PE)
* Mechanical ventilation
* Acute respiratory distress syndrome (ARDS)

Pulmonary hypertension may occur secondary to left-sided heart disease, primary pulmonary hypertension or significant pulmonary disease (e.g. COPD).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What are the five overarching causes of chronic heart failure? [5]

State common causes for each [+]

A

Vascular
* Ischaemic heart disease
* Hypertension

Muscular
* Dilated cardiomyopathy (30%)
* Hypertrophic cardiomyopathy
* Congenital heart disease

Valvular
* Commonly aortic stenosis

Arrhythmias
* commonly atrial fibrillation

High-output failures
* Anaemia
* Septicaemia
* Thyrotoxicosis
* Liver failure

High output failures:
- Typically heart failure is caused by a reduced cardiac output. In some cases, however, the cardiac output may be raised but the systemic vascular resistance very low

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What is a normal EF? [1]

A

An ejection fraction above 50% is considered normal.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Describe what is meant by heart failure with reduced ejection fraction? [1]

Describe what is meant by heart failure withpreserved ejection fraction? [1]

A

HFrEF:
* ejection fraction is less than 50%.

HFpEF:
* when someone has the clinical features of heart failure but an ejection fraction greater than 50%.
* result of diastolic dysfunction, where there is an issue with the left ventricle filling with blood during diastole (the ventricle relaxing).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Describe the different NYHA classifications for the severity of HF [4]

A

NYHA Class I
* no symptoms
* no limitation: ordinary physical exercise does not cause undue fatigue, dyspnoea or palpitations

NYHA Class II
* mild symptoms
* slight limitation of physical activity: comfortable at rest but ordinary activity results in fatigue, palpitations or dyspnoea

NYHA Class III
* moderate symptoms
* marked limitation of physical activity: comfortable at rest but less than ordinary activity results in symptoms

NYHA Class IV
* severe symptoms
* unable to carry out any physical activity without discomfort: symptoms of heart failure are present even at rest with increased discomfort with any physical activity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What are the symptoms of HF? [6]

A
  • Breathlessness, worsened by exertion
  • Cough, which may produce frothy white/pink sputum
  • Orthopnoea, which is breathlessness when lying flat, relieved by sitting or standing (ask how many pillows they use)
  • Paroxysmal nocturnal dyspnoea (suddenly waking at night with a severe attack of shortness of breath, cough and wheeze.)
  • Peripheral oedema
  • Fatigue
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Describe the signs of HF [+]

A
  • Tachycardia (raised heart rate)
  • Tachypnoea (raised respiratory rate)
  • Hypertension
  • Murmurs on auscultation indicating valvular heart disease
  • Peripheral oedema of the ankles, legs and sacrum
  • Raised JVP
  • Displaced apex
  • Heart sounds S3/S4
  • Pulsus alternans
  • Hepatomegaly
  • Ascites
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Describe what is meant by Paroxysmal Nocturnal Dyspnoea (PND) [2]

Explain why this occurs [3]

A

Experience that patients have of suddenly waking at night with a severe attack of shortness of breath, cough and wheeze.

They may describe having to sit on the side of the bed or walk around the room, gasping for breath

Pathophysiology:
- Fluid settles across a large surface area of the lungs as they lie flat to sleep, causing breathlessness. As they stand up, the fluid sinks to the lung bases, and the upper lung areas function more effectively
AND
- respiratory centre in the brain becomes less responsive. the respiratory rate and effort do not increase in response to reduced oxygen saturation like they would when awake.
AND
- there is less adrenalin circulating during sleep. Less adrenalin means the myocardium is more relaxed, reducing cardiac output.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Describe how you investigate for HF [+]

A

All patients given N-terminal pro-B-type natriuretic peptide (NT‑proBNP) blood test first-line:
- If high: arrange specialist assessment (including transthoracic echocardiography) within 2 weeks
- if levels are ‘raised’ arrange specialist assessment (including transthoracic echocardiography) echocardiogram within 6 weeks

Other investigations include:
* ECG
* Bloods for anaemia, renal function, thyroid function, liver function, lipids and diabetes
* Chest x-ray and lung function tests to exclude lung pathology

B-type natriuretic peptide (BNP) is a protein released by cardiomyocytes in response to excessive stretching

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

A [] is the main investigation for the confirmation of heart failure.

A

A transthoracic echocardiography (TTE) is the main investigation for the confirmation of heart failure.

26
Q

A transthoracic echocardiography (TTE) is the main investigation for the confirmation of heart failure.

What is the main determinant of a TTE in HF?
State the different values for ^ [3]

A

The main determinant of an TTE is to look at the ejection fraction of the heart. This helps to differentiate suspected heart failure into three groups:
* Heart failure with reduced ejection fraction (HFrEF): LVEF < 40%
* Heart failure with minimally reduced ejection fraction (HFmrEF): LVEF 40-49%
* Heart failure with preserved ejection fraction (HFpEF): LVEF ≥50%

27
Q

What are you looking for to that might indicate HF in an ECHO [3] or CXR [5]

A

Echocardiogram:
* Evidence of previous MI
* Left ventricular strain / hypertrophy
* Conduction abnormalities / AF

CXR:
* Cardiomegaly (Cardiothoracic ratio > 50% on PA film)
* Alveolar shadowing oedema
* Kerley B lines (fluid in septae of secondary lobules)
* Pleural effusion
* Upper lobe diversion

28
Q

How would you specifically investigate RHF? [1]

A

Right heart catheterisation: reserved for the investigation of right-sided heart failure

29
Q

How would you specifically investiage for an arrhythmia causing HF? [1]

A

24 hr ECG

30
Q

How would you specifically investiage for coronary artery disease causing HF? [1]

A

Coronary angiogram

31
Q

What are normal, raised and high levels of BNP and NTproBNP? [9]

A
32
Q

Name some causes apart from HF that raise BNP [5]

A

diabetes, sepsis, old age, hypoxaemia (PE and COPD), kidney disease, and liver cirrhosis

33
Q

The urgency of the referral and specialist assessment depends on the NT-proBNP result. According to the NICE guidelines:

From [] to [] ng/litre should be seen and have an echocardiogram within 6 weeks

Above [] ng/litre should be seen and have an echocardiogram within 2 weeks

A

From 400 – 2000 ng/litre should be seen and have an echocardiogram within 6 weeks

Above 2000 ng/litre should be seen and have an echocardiogram within 2 weeks

34
Q

Describe the treatment algorithm for HF

A

First-line treatment:
- for all patients is both an ACE-inhibitor and a beta-blocker
- Generally, one drug should be started at a time

Second-line treatment:
- aldosterone antagonist, angiotensin II receptor blocker or a hydralazine in combination with a nitrate

Continued symptoms:
- cardiac resynchronisation therapy
- digoxin
- ivabradine
- SGLT2 inhibitors
- Sacubitril with valsartan (brand name Entresto)

ABAL: ACEin; Beta Blocker; Aldosterone antagonist; Loop diuertic

35
Q
A

bisoprolol, carvedilol, and nebivolol.

36
Q

What criteria has to be met for ivabradine to be indicated in a HF patient? [3]

A

Already on a :
- ACE-inhibitor, beta-blocker + aldosterone antagonist
- has a heart rate > 75/min
- and a left ventricular fraction < 35%

37
Q

Avoid [] in patients with valvular heart disease until initiated by a specialist.

ACE inhibitor
Beta blocker
Aldosterone antagonist
Loop diuretic

A

Avoid [] in patients with valvular heart disease until initiated by a specialist.

ACE inhibitor
Beta blocker
Aldosterone antagonist
Loop diuretic

38
Q

Which tx for HF need close renal monitoring when used in combination? [2]

A

It is particularly essential to closely monitor the renal function in patients taking ACE inhibitors and aldosterone antagonists as both cause hyperkalaemia

39
Q

Cardiac resynchronisation therapy (CRT) may be used in severe heart failure, with an ejection fraction of less than []%.

What NYHA classification do they need to meet? [2]

A

Cardiac resynchronisation therapy (CRT) may be used in severe heart failure, with an ejection fraction of less than 35%.

NYHA III or IV

40
Q

Describe how cardiac resynchronisation therapy (CRT) works [1]

A

CRT involves biventricular (triple chamber) pacemakers, with leads in the right atrium, right ventricle and left ventricle.

The objective is to synchronise the contractions in these chambers to optimise heart function.

41
Q

If a patient remains symptomatic despite optimal treatment what interventions using a device can be used in selected patients? [4]

A

Implantable cardiac defibrillator (ICD):
* important for primary and secondary prevention of sudden cardiac death (specific indications)
.
Cardiac resynchronisation therapy (CRT):
* biventricular pacing, which is indicated in certain patients with HFrEF (i.e. ≤ 35%) & prolonged QRS (i.e. ≥ 130 ms). Usually receive combined device with defibrillator.

Percutaneous coronary intervention (PCI):
* patients with ischaemic heart disease may be offered revascularisation therapy if indicated.|

Cardiac transplant:
* highly specialised procedure for certain patient groups with heart failure.

42
Q

How do you treat heart failure with preserved LVEF? [1]

A

A loop diuretic (e.g. furosemide) may be given if the patient has symptomatic fluid overload.

Insufficient evidence exists for the role of ACE-inhibitors, ARBs, and beta-blockers in heart failure with preserved LVEF.

43
Q

Explan your answer [1]

A

Left ventricular aneurysm

The ischaemic damage sustained may weaken the myocardium resulting in aneurysm formation. This is typically associated with persistent ST elevation and left ventricular failure. Thrombus may form within the aneurysm increasing the risk of stroke. Patients are therefore anticoagulated.

44
Q

What is the most common mechanism resulting in heart failure in patients with hypertrophic obstructive cardiomyopathy?

Systolic HF
Diastolic HF
Highoutput HF

A

What is the most common mechanism resulting in heart failure in patients with hypertrophic obstructive cardiomyopathy?

Systolic HF
Diastolic HF
Highoutput HF

45
Q

Name the four causes of diastolic HF [4]

A
  • cardiac tamponade
  • hypertrophic obstructive cardiomyopathy
  • constrictive pericarditis
  • restrictive cardiomyopathy
46
Q

Name the four causes of systolic HF [4]

A
  • ischaemic heart disease
  • arrhythmias
  • myocarditis
  • dilated cardiomyopathy
47
Q

When considering third line therapy for chronic heart failure, which drugs can be considered?[5]

A

Ivabradine

sacubitril-valsartan

digoxin

hydralazine in combination with nitrate

cardiac resynchronisation therapy

48
Q

A patient has chronic heart failure. You trial and ACEI but the patient is intolerant.

You then trial an ARB, but the patient is still intolerant.

What treatment should you consider nexr? [1]

A

Hydralazine and nitrate

49
Q

Describe how you were determine if you give each of the following for third line chronic HF tx?

Ivabradine

sacubitril-valsartan

hydralazine in combination with nitrate

cardiac resynchronisation therapy

A

Ivabradine
- sinus rhythm > 75/min and a left ventricular fraction < 35%

sacubitril-valsartan:
- criteria: left ventricular fraction < 35%
- is considered in heart failure with reduced ejection fraction who are symptomatic on ACE inhibitors or ARBs

digoxin

hydralazine in combination with nitrate
- this may be particularly indicated in Afro-Caribbean patients

cardiac resynchronisation therapy
- indications include a widened QRS (e.g. left bundle branch block) complex on ECG

50
Q

A patient has chronic heart failure.

You iniate an ACEin and a BB as first line treatment. This does not resolve their EF.

You next trial and aldosterone antagonist. This does also not help.

They are Afro-Carribean.

What is the appropriate third line treatment?

  • Ivabradine
  • sacubitril-valsartan
  • digoxin
  • hydralazine in combination with nitrate
  • cardiac resynchronisation therapy
A
  • hydralazine in combination with nitrate
51
Q

A patient has chronic heart failure.

You iniate an ACEin and a BB as first line treatment. This does not resolve their EF.

You next trial and aldosterone antagonist. This does also not help.

They have a widened QRS on their ECG.

What is the appropriate third line treatment?

  • Ivabradine
  • sacubitril-valsartan
  • digoxin
  • hydralazine in combination with nitrate
  • cardiac resynchronisation therapy
A

A patient has chronic heart failure.

You iniate an ACEin and a BB as first line treatment. This does not resolve their EF.

You next trial and aldosterone antagonist. This does also not help.

They have a widened QRS on their ECG.

What is the appropriate third line treatment?

  • Ivabradine
  • sacubitril-valsartan
  • digoxin
  • hydralazine in combination with nitrate
  • cardiac resynchronisation therapy
52
Q

A patient has chronic heart failure.

You iniate an ACEin and a BB as first line treatment. This does not resolve their EF.

You next trial and aldosterone antagonist. This does also not help.

They have LVEF < 35% and symptomatic

What is the appropriate third line treatment?

  • Ivabradine
  • sacubitril-valsartan
  • digoxin
  • hydralazine in combination with nitrate
  • cardiac resynchronisation therapy
A

A patient has chronic heart failure.

You iniate an ACEin and a BB as first line treatment. This does not resolve their EF.

You next trial and aldosterone antagonist. This does also not help.

They have LVEF < 35% and symptomatic

What is the appropriate third line treatment?

sacubitril-valsartan

53
Q

A patient has chronic heart failure.

You iniate an ACEin and a BB as first line treatment. This does not resolve their EF.

You next trial and aldosterone antagonist. This does also not help.

They have LVEF < 35% and a sinus rhythm of 90bpm

What is the appropriate third line treatment?

  • Ivabradine
  • sacubitril-valsartan
  • digoxin
  • hydralazine in combination with nitrate
  • cardiac resynchronisation therapy
A

A patient has chronic heart failure.

You iniate an ACEin and a BB as first line treatment. This does not resolve their EF.

You next trial and aldosterone antagonist. This does also not help.

They have LVEF < 35% and a sinus rhythm of 90bpm

What is the appropriate third line treatment?

Ivabradine

54
Q

Describe what is meant by cardiorenal syndrome [2]

How is this managed? [1]

A

Cardiac output drops sufficiently to result in renal dysfunction

The reduced cardiac function causes hypotension, tachycardia, reduced peripheral perfusion, and hepatic congestion

Hyponatraemia occurs because of dilutional effect of heart failure.

Increased doses of diuretics are required to improve cardiac contractility, improve cardiac output, and thus increase renal perfusion.

55
Q
A
56
Q

What is the recommended treatment for all patients with acute heart failure? [1]

Which drug class is generally contraindicated? [1]

A

IV furosemide or bumetanide

Nitrates are generally contraindicated

57
Q

When are nitrates considered in the treatment of acute heart failure patients? [3]

A

Acute HF +
- concomitant myocardial ischaemia
- severe hypertension
- regurgitant aortic or mitral valve disease

58
Q

A patient has acute HF.

You prescribe them IV furosemide, but they continue to have respiratory failure.

What is the next appropriate management? [1]

A

CPAP

59
Q

A patient presents with acute heart failure.

Under what conditions would you consider prescribing intropric agents to them? [1]

A

Acute HF +
- patients with severe left ventricular dysfunction who have potentially reversible cardiogenic shock

60
Q

A patient presents with acute heart failure. You suspect that they have severe left ventricular dysfunction, with a potentially reversible cardiogenic shock.

What is your next stage in management [1]

A

Add an inotropic agent (such as dobutamine)

61
Q

When do you discontinue beta-blockers for patients with acute HF? [1]

A

heart rate less than 50 beats per minute, second or third degree atrioventricular block, or shock

62
Q

A patient has acute HF.

Under what circumstances would you prescribe norepinephrine? [1]

A

If hypotensive / in cardiogenic shock and have an insufficient response to inotropes and there is evidence of end-organ hypoperfusion